Venturi Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $27.8M | Buy |
23,196
+180
| +0.8% | +$184K | 1.08% | 22 |
|
|
2026
Q1 | $21.2M | Sell |
23,016
-392
| -2% | -$397K | 0.95% | 26 |
|
|
2025
Q4 | $25.2M | Buy |
23,408
+330
| +1% | +$316K | 1.12% | 20 |
|
|
2025
Q3 | $17.6M | Buy |
23,078
+507
| +2% | +$377K | 0.82% | 35 |
|
|
2025
Q2 | $17.6M | Buy |
22,571
+1,288
| +6% | +$1M | 0.87% | 32 |
|
|
2025
Q1 | $17.6M | Buy |
21,283
+3,467
| +19% | +$2.88M | 0.91% | 24 |
|
|
2024
Q4 | $13.8M | Buy |
17,816
+1,101
| +7% | +$912K | 0.68% | 41 |
|
|
2024
Q3 | $14.8M | Sell |
16,715
-1,247
| -7% | -$1.12M | 0.78% | 36 |
|
|
2024
Q2 | $16.3M | Sell |
17,962
-257
| -1% | -$206K | 0.96% | 21 |
|
|
2024
Q1 | $14.2M | Sell |
18,219
-2,826
| -13% | -$2.01M | 0.91% | 20 |
|
|
2023
Q4 | $12.3M | Sell |
21,045
-87
| -0.4% | -$50.8K | 0.87% | 30 |
|
|
2023
Q3 | $11.4M | Buy |
21,132
+19,028
| +904% | +$9.81M | 0.89% | 23 |
|
|
2023
Q2 | $987K | Buy |
2,104
+53
| +3% | +$22.2K | 0.08% | 155 |
|
|
2023
Q1 | $704K | Sell |
2,051
-21
| -1% | -$7.08K | 0.06% | 204 |
|
|
2022
Q4 | $758K | Sell |
2,072
-2
| -0.1% | -$709 | 0.07% | 201 |
|
|
2022
Q3 | $671K | Sell |
2,074
-46
| -2% | -$14.6K | 0.06% | 198 |
|
|
2022
Q2 | $687K | Hold |
2,120
| – | – | 0.06% | 186 |
|
|
2022
Q1 | $607K | Buy |
2,120
+1,007
| +90% | +$259K | 0.05% | 224 |
|
|
2021
Q4 | $307K | Buy |
+1,113
| New | +$282K | 0.02% | 285 |
|
|
2020
Q3 | – | Sell |
-5,254
| Closed | -$863K | – | 292 |
|
|
2020
Q2 | $863K | Sell |
5,254
-48,610
| -90% | -$7.46M | 0.12% | 117 |
|
|
2020
Q1 | $7.47M | Sell |
53,864
-17,759
| -25% | -$2.44M | 1.28% | 24 |
|
|
2019
Q4 | $9.41M | Buy |
71,623
+905
| +1% | +$105K | 1.14% | 27 |
|
|
2019
Q3 | $7.91M | Buy |
70,718
+3,339
| +5% | +$372K | 1.02% | 37 |
|
|
2019
Q2 | $7.46M | Buy |
+67,379
| New | +$7.93M | 1.01% | 39 |
|
|
2017
Q2 | – | Sell |
-6,672
| Closed | -$542K | – | 198 |
|
|
2017
Q1 | $542K | Sell |
6,672
-73,399
| -92% | -$5.88M | 0.13% | 123 |
|
|
2016
Q4 | $5.89M | Buy |
80,071
+7,165
| +10% | +$534K | 1.66% | 25 |
|
|
2016
Q3 | $5.85M | Buy |
72,906
+1,345
| +2% | +$108K | 1.94% | 17 |
|
|
2016
Q2 | $5.63M | Buy |
71,561
+2,867
| +4% | +$216K | 1.91% | 14 |
|
|
2016
Q1 | $4.95M | Buy |
68,694
+14,824
| +28% | +$1.12M | 1.85% | 16 |
|
|
2015
Q4 | $4.54M | Buy |
+53,870
| New | +$4.47M | 2.06% | 10 |
|
Other funds holding LLY
Venturi Wealth Management's LLY Position: Q2 2026 in Review
Venturi Wealth Management increased its Eli Lilly (LLY) stake by 0.78% in Q2 2026, buying an estimated $184K and bringing the position to 23,196 shares worth $27.8M. The position accounts for 1.08% of the portfolio, ranked #22.
Venturi Wealth Management first reported a position in LLY in Q4 2015 and has held it in 30 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Venturi Wealth Management held 23,196 shares of Eli Lilly worth $27.8M as of Q2 2026.
- Venturi Wealth Management bought 180 Eli Lilly shares in Q2 2026, an estimated $184K.
- Eli Lilly made up 1.08% of Venturi Wealth Management's portfolio in Q2 2026, its #22 holding.
- Venturi Wealth Management first reported a position in Eli Lilly in Q4 2015 and has held it in 30 quarters since.
- 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Venturi Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.